Home Featured Page 163

Featured

Latest

Psychedelic Policy Briefing: Week of June 29nd, 2026

A Country That Recalls Its Own Forgetting

Pα+ Psychedelic Bulletin #226: The Ethics of Psilocybin for Advanced Alzheimer’s; Veterans’ Views on Psychedelics

A Research Hypothesis, Not A Treatment Recommendation: Marcos Lago on the Viral Psilocybin for Alzheimer’s Case Report

Small Pharma to Participate in Upcoming September Investor Conferences

Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History

Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of...

Psyence Group Announces Amendment and Closing of Previously Announced Private Placement

atai Life Sciences to Participate in September Investor Events

Mindset Pharma Files National Patents Protecting Family 1 Application in 16...

Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida...

BetterLife and Collaborators to Submit Key Joint Research Publication

MindMed to Participate in H.C. Wainwright Global Investment ConferenceUSA – EnglishUSA...

PharmaTher Announces Completion of IND-Enabling Pharmacokinetic and Tolerability Study with KETARX™...

EDITOR PICKS

Psychedelic Policy Briefing: Week of June 29nd, 2026

A Country That Recalls Its Own Forgetting

Pα+ Psychedelic Bulletin #226: The Ethics of Psilocybin for Advanced Alzheimer’s;...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psychedelic Policy Briefing: Week of June 29nd, 2026

A Country That Recalls Its Own Forgetting

Pα+ Psychedelic Bulletin #226: The Ethics of Psilocybin for Advanced Alzheimer’s; Veterans’ Views on Psychedelics

A Research Hypothesis, Not A Treatment Recommendation: Marcos Lago on the Viral Psilocybin for Alzheimer’s Case Report

Psychedelics & Society

Small Pharma to Participate in Upcoming September Investor Conferences

Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History

Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of...

Psyence Group Announces Amendment and Closing of Previously Announced Private Placement

atai Life Sciences to Participate in September Investor Events

Mindset Pharma Files National Patents Protecting Family 1 Application in 16...

Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida...

BetterLife and Collaborators to Submit Key Joint Research Publication

MindMed to Participate in H.C. Wainwright Global Investment ConferenceUSA – EnglishUSA...

PharmaTher Announces Completion of IND-Enabling Pharmacokinetic and Tolerability Study with KETARX™...

EDITOR PICKS

Psychedelic Policy Briefing: Week of June 29nd, 2026

A Country That Recalls Its Own Forgetting

Pα+ Psychedelic Bulletin #226: The Ethics of Psilocybin for Advanced Alzheimer’s;...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY